Best Doctors for Chemotherapy in Chennai, India

Dr. J. Jebasingh is a Senior Consultant in Medical Oncology at the Cancer Centre of Rela Institute & Medical Centre in Chennai, India, with more than 33 years of clinical expertise in comprehensive cancer care. He holds a DM in Medical Oncology from Madras Medical College (2006), an MD in Radiotherapy from Madurai Medical College (1999), a DNB in General Medicine from Meenakshi Mission Hospital & Research Centre (2000), and an MBBS from the prestigious Christian Medical College (1993). His deep foundation across radiotherapy, general medicine, and medical oncology positions him uniquely to manage complex malignancies with integrated, evidence-based approaches. Dr. Jebasingh specializes in chemotherapy, cancer immunotherapy, targeted therapy, and hormone therapies for breast, gynecologic, and prostate cancers. He brings particular expertise in bone marrow transplantation and emerging CAR-T cell therapy. His clinical career has been enriched by active participation in rigorous clinical trials, including bio-equivalence studies of liposomal doxorubicin and temozolomide, and maintenance pemetrexed protocols in non-squamous lung cancer. He has presented findings at nearly 40 international and regional oncology conferences and has authored research on nasopharyngeal cancer, neo-adjuvant response assessment in osteosarcoma, and glucose tolerance outcomes in cancer populations. This combination of bedside practice and investigative rigor ensures his patients benefit from the latest therapeutic advances. Dr. Jebasingh has trained extensively in specialized oncology domains, including bone marrow transplantation at Cancer Institute, Adyar, and pediatric and gynecological oncology at the Institute of Child Health and Institute of Obstetrics & Gynaecology, Chennai. He maintains currency through continuing medical education, having completed a Johns Hopkins University certification on breast cancer updates. He welcomes international patients from the Gulf, Africa, and South Asia, offering compassionate, personalized cancer management with fluency in English, Hindi, and Tamil. His holistic approach integrates supportive care alongside curative and palliative strategies. Rela Institute & Medical Centre is one of India's leading multi-specialty hospitals, accredited by JCI and NABH, with state-of-the-art oncology facilities, dedicated ICU support, and an established international patient services desk. The hospital's cancer centre combines cutting-edge diagnostic imaging, advanced chemotherapy infusion units, and hematology-oncology laboratories. For international patients, the hospital arranges rapid visa documentation support, accommodation coordination, and flexible telemedicine follow-ups. Dr. Jebasingh's 33+ years of dedicated oncology practice, combined with Rela's world-standard infrastructure and patient-centric services, makes Chennai an increasingly preferred destination for complex cancer care among patients across Asia, the Middle East, and Africa.

Dr. K. R. Gopi is a Senior Consultant Medical Oncologist with more than 30 years of clinical experience in oncology and palliative care. He holds multiple prestigious international qualifications including MRCP (Royal College of Physicians, Ireland), Medical Oncology Certification from the Royal College of Physicians (United Kingdom), European Board Certification in Medical Oncology, and DNB (National Board of Examinations, India). His career reflects a unique blend of international expertise, having trained and practiced across prestigious NHS hospitals in the United Kingdom and leading healthcare institutions in India. Dr. Gopi's clinical practice spans the full spectrum of solid tumors and hematological malignancies, including breast cancer, colorectal cancer, ovarian cancer, prostate cancer, lymphoma, leukemia, and hepato-biliary-pancreatic cancers. He specializes in modern treatment modalities including chemotherapy, cancer immunotherapy, targeted therapy, and hormone therapy across multiple cancer types. His expertise extends to managing cancer in elderly and frail patients, post-transplant lymphoproliferative disorders, and advanced palliative care. Notably, he pioneered the introduction of subcutaneous morphine infusion in India, having successfully treated hundreds of terminally ill patients with this compassionate approach to end-of-life care. Throughout his career, Dr. Gopi has actively participated in major clinical research initiatives and landmark trials in the United Kingdom, including pivotal studies for Trastuzumab (HERA), Bevacizumab, Rituximab, Imatinib, Sunitinib, Letrozole, and Panitumumab. He has presented his clinical work at numerous national and international conferences, contributing to the advancement of oncology practice. His experience treating international patients from the Gulf, Africa, and across the Indian subcontinent ensures he understands the unique needs of medical tourists seeking quality cancer care. Dr. Gopi practices at Dr. Rela Institute and Medical Centre in Chennai, one of India's premier multi-specialty hospitals known for its advanced oncology infrastructure, state-of-the-art diagnostic facilities, and comprehensive cancer care programs. The hospital combines cutting-edge technology with compassionate patient-centered care, making it an ideal destination for international patients. Dr. Rela Institute maintains international standards of clinical practice and offers dedicated support services for overseas patients, including interpretation assistance and personalized treatment coordination. International patients choosing Dr. Gopi benefit from a physician whose clinical training spans both the United Kingdom and India, bringing global best practices to local care. Whether seeking first-line cancer treatment, a second opinion, or specialized palliative care, patients can expect evidence-based medicine delivered with deep empathy and cultural sensitivity.

Dr. Prasad E is Head of Department and Senior Medical Oncologist at Apollo Proton Cancer Centre in Chennai, bringing over 22 years of dedicated expertise in medical oncology. He holds multiple advanced qualifications including MBBS, MD, DNB, and DMRT, positioning him among the most comprehensively trained oncologists in South India. His clinical foundation combines classical oncology training with cutting-edge brachytherapy and radiotherapy knowledge, earned through international study and recognition. Dr. Prasad E specializes in the full spectrum of solid tumour management, with deep clinical experience in chemotherapy protocols—adjuvant, neoadjuvant, and palliative approaches. His practice increasingly focuses on precision oncology: immune checkpoint inhibitor therapy, targeted molecular therapy based on biomarkers, and hormone therapy for breast cancer. He has presented his clinical research on advanced radiotherapy techniques at the American Society for Therapeutic Radiology and Oncology (ASTRO) and received international training recognition from the American Brachytherapy Society, underscoring his commitment to evidence-based innovation. International patients form a significant part of Dr. Prasad's practice, with patients regularly travelling from the Gulf States, North Africa, and across South Asia for his expertise. He is fluent in English, Tamil, and Hindi, ensuring clear communication and culturally sensitive care. His approach emphasizes comprehensive patient education, enabling individuals from diverse backgrounds to make informed treatment decisions aligned with their values and circumstances. Apollo Proton Cancer Centre represents one of India's premier oncology destinations, combining advanced diagnostic imaging, state-of-the-art chemotherapy suites, and proton therapy facilities—a rare combination outside the West. The hospital's international patient services team and NABH accreditation ensure seamless coordination for medical tourists. Located in Chennai, a well-connected hub with direct flights from Gulf capitals and Africa, the centre offers cost-effective, world-standard cancer care within a supportive ecosystem. International patients choosing Dr. Prasad benefit from transparent, outcome-focused treatment planning, access to cutting-edge therapies, and a hospital infrastructure designed to accommodate family members and post-treatment follow-up coordination across borders.

Dr. Julius Xavier Scott is a distinguished paediatric hemato-oncologist and Director of the Department of Paediatric Hemato-Oncology at Rela Hospital, Chennai. With over 22 years of clinical experience, he brings exceptional expertise in managing complex blood disorders and cancers in children. He holds advanced qualifications including an MD in Paediatrics, DNB (Paediatrics), and a Fellowship in Paediatric Hemato-Oncology from the Women's and Children's Hospital in Adelaide, Australia, ensuring his practice reflects both Indian and international standards of care. Dr. Scott's clinical repertoire encompasses the full spectrum of paediatric haematological and oncological conditions: childhood leukaemias, lymphomas, solid tumours, bone marrow transplantation, retinoblastoma, aplastic anaemia, thalassaemia, sickle cell disease, and immunodeficiency disorders. He has authored over 140 peer-reviewed publications and contributed multiple chapters to leading textbooks in his field. His educational leadership extends through annual refresher courses that train over 500 junior doctors, reflecting his commitment to advancing paediatric oncology practice across India. International patients from across the Gulf region, Africa, and South Asia regularly seek Dr. Scott's care for complex cases requiring specialist management and a compassionate approach. At Rela Hospital, he combines cutting-edge treatment protocols with holistic palliative care, ensuring families receive comprehensive support throughout the child's journey. His work has been recognized with awards including the Best Doctor Award from the Rotary Club of Chennai Towers (2013) and the International Healthcare Award (2016). Rela Hospital, where Dr. Scott practises, is a leading multi-specialty centre in Chennai equipped with advanced haematology and oncology units, a dedicated paediatric ICU, and modern bone marrow transplant facilities. The hospital maintains NABH accreditation and provides coordinated care through an international patient services desk. For families seeking expert paediatric blood and cancer care with a blend of Indian clinical excellence and global best practice, Dr. Scott's team at Rela Hospital offers a trusted destination with proven outcomes and compassionate family-centred care.

Dr. S. Viswanath is a Senior Consultant in Medical Oncology with over 17 years of dedicated experience in cancer medicine. A former Brigadier in the Indian Armed Forces Medical Services, he brings exceptional clinical discipline and compassionate care to every patient encounter. He holds an MD in General Medicine from Command Hospital (Airforce), Bangalore, and a DM in Medical Oncology from the prestigious Cancer Institute (WIA) in Adyar, Chennai—institutions recognized for rigorous oncological training. Dr. Viswanath has managed a broad spectrum of malignancies across his career, spanning chemotherapy, targeted therapy, hormone therapy, immunotherapy, and advanced CAR-T cell therapy. His academic contributions include published research on rheumatoid arthritis, bronchogenic carcinoma, and lymphoma in peer-reviewed journals, demonstrating his commitment to evidence-based oncology. Throughout his military tenure, he served in progressively senior roles—from Assistant Professor to Senior Advisor and Professor—at premier military hospitals across India, including Command Hospital (Western Command) and Army Hospital (Research & Referral) in New Delhi. His leadership credentials include serving as Commandant of Military Hospital, Chennai, underscoring his organizational and clinical expertise. At Rela Hospital's Cancer Centre in Chennai, Dr. Viswanath treats international patients from the Gulf region, Africa, and South Asia seeking world-standard oncological care. He works closely with multidisciplinary teams to develop personalized treatment plans that balance aggressive cancer control with quality of life. His proficiency in English, Hindi, and Tamil facilitates seamless communication with patients from diverse backgrounds. International patients particularly value his methodical approach to complex cases and his ability to integrate the latest chemotherapy protocols with emerging immunotherapeutic strategies. Rela Hospital is a Joint Commission International (JCI)-accredited centre of excellence located in Chennai, a major medical tourism hub in South India. The hospital's Cancer Centre is equipped with advanced diagnostic imaging, dedicated oncology wards, and supportive care facilities that meet international standards. The institution's strong reputation for outcomes in breast cancer, hematologic malignancies, and solid tumours, combined with comprehensive patient support services and transparent pricing, makes it an attractive destination for international patients. For those seeking expert cancer management with a physician who combines military-honed precision with cutting-edge oncological science, Dr. Viswanath offers both clinical depth and the reassurance of treatment at a globally recognized facility.

Dr. Ponni Sivaprakasam is a Senior Consultant in Medical Oncology at Gleneagles Global Health City in Chennai, bringing over 17 years of clinical expertise in cancer care and blood disorders. She holds an MRCPCH qualification from the Royal College of Paediatrics and Child Health, London, and has completed specialized fellowships in clinical pediatric hematology-oncology and bone marrow transplantation from leading UK institutions including The Hospital for Sick Children and Bristol Royal Hospital for Children. Her international distinction includes recognition as a JACIE inspector by the European Blood and Marrow Transplantation group, a role that involves inspecting and accrediting bone marrow transplant centers worldwide to maintain global quality standards. Dr. Sivaprakasam's clinical practice encompasses the full spectrum of medical oncology, with particular expertise in pediatric hemato-oncology, bone marrow and stem cell transplantation, chemotherapy protocols, cancer immunotherapy, and targeted therapies including CAR-T cell therapy. She has published peer-reviewed research in high-impact journals on mesenchymal stromal cell therapy for graft-versus-host disease and adenovirus infection in transplant recipients, demonstrating her engagement with advancing cancer and transplant medicine. Her case management spans complex pediatric and adult cancer patients, and she leads multidisciplinary teams in treatment planning and long-term follow-up care. International patients from the Gulf, Africa, and South Asia find Dr. Sivaprakasam's clinic a welcoming environment. She communicates fluently in English, Hindi, and Tamil, and her experience managing cross-border patient logistics is substantial. Patients appreciate her systematic approach to diagnosis, evidence-based treatment planning, and transparent communication about prognosis and options. The clinic coordinates closely with Gaf Healthcare to arrange remote consultations, medical record review, and seamless admission processes for patients traveling to Chennai for treatment. Gleneagles Global Health City is a JCI-accredited, multi-specialty tertiary care facility with dedicated oncology and transplant units, advanced diagnostic imaging, and on-site blood bank facilities. The hospital's international patient services team manages visa support, accommodation liaison, and currency exchange for overseas visitors. The institution's commitment to evidence-based practice and infrastructure for complex cancer care makes it an established choice for international patients seeking comprehensive oncology management in South India. International patients should know that Dr. Sivaprakasam's clinic operates with clear pathways for virtual consultation, document review prior to travel, and pre-treatment planning. Treatment timelines and costs are discussed openly, and follow-up care can be coordinated with local oncologists after the patient returns home. Chennai's modern airport connectivity and lower cost of care compared to Western centers make it an accessible option for families managing serious cancer diagnoses.

Dr. Arun Ramanan V is Clinical Lead and Senior Consultant in Medical Oncology at Gleneagles HealthCity Chennai, one of India's leading cancer care institutions. With over 16 years of clinical experience, he holds a DM (Medical Oncology) from Madras Medical College and is a Fellow of the Indian Academy of Palliative Medicine (FIPM). His clinical expertise spans comprehensive cancer management, including chemotherapy for solid and haematologic malignancies, bone marrow transplantation, immunotherapy, targeted therapy, and advanced radiotherapy techniques. Dr. Arun Ramanan has served as Principal Investigator in multiple Phase II–IV clinical trials involving immunotherapies, biosimilars, and targeted therapies, bringing cutting-edge evidence-based treatment to his patients. His specialization includes breast cancer oncology, lung cancer oncology, gastrointestinal malignancies, and personalized precision medicine. He has published eight original research articles and two case reports in reputed national and international journals, demonstrating his commitment to advancing oncology knowledge and clinical practice. International patients from the Gulf countries, East Africa, and South Asia increasingly seek his care for complex and rare cancers. Dr. Arun Ramanan combines his extensive clinical acumen with a compassionate, patient-centered approach. He is fluent in English, Hindi, and Tamil, and actively mentors postgraduate fellows and conducts regular continuing medical education programs. His recognition as "Best Doctor" by the Government of Tamil Nadu in 2022–2023 and 2023–2024 underscores his clinical excellence and community trust. Gleneagles HealthCity Chennai, located in Perumbakkam, is a NABH-accredited multispecialty institution equipped with state-of-the-art oncology departments, advanced imaging, and dedicated international patient services. The hospital's tumour board approach and multidisciplinary team ensure every patient receives integrated, evidence-based care. For international patients, the hospital provides comprehensive visa assistance, accommodation coordination, and medical record translation services, making cancer care accessible and stress-free.

Dr. Dhaarani J is a Consultant Paediatric Hemato-Oncologist at Dr. Rela Institute & Medical Centre in Chennai, bringing over 13 years of dedicated clinical experience to the care of children with blood disorders and childhood cancers. She holds an MD from PGIMER Chandigarh, one of India's most prestigious medical institutions, and is fellowship-trained by the National Board of Examinations and the Indian Academy of Paediatrics in paediatric hemato-oncology. Her clinical journey spans more than 5 years of independent specialist practice, during which she has developed deep expertise in managing complex haematological and oncological conditions in children. Dr. Dhaarani specializes in paediatric bone marrow transplantation, hematopoietic stem cell transplantation, and the treatment of conditions including paediatric leukemia, thalassemia, sickle cell disease, and aplastic anemia. Her clinical work extends to primary immunodeficiencies and rare paediatric syndromes with genetic and autoimmune underpinnings. She has published over 70 peer-reviewed articles, case reports, and clinical studies, establishing herself as an active contributor to paediatric hemato-oncology literature. In 2023, she served as Organising Secretary of PHOCON, the national conference for paediatric hemato-oncology experts, reflecting her standing within the Indian paediatric oncology community. Dr. Dhaarani regularly treats international patients from the Gulf region, Africa, and South Asia who seek advanced paediatric cancer and blood disorder care. She brings compassionate, family-centered communication and is fluent in English, Hindi, and Tamil, ensuring that families from diverse backgrounds feel supported throughout treatment. Her international patient experience encompasses complex cases requiring long-term follow-up, donor coordination for transplantation, and multidisciplinary symptom management. At Dr. Rela Institute & Medical Centre, a NABH-accredited tertiary care facility in Chennai, Dr. Dhaarani benefits from state-of-the-art paediatric oncology infrastructure, dedicated ICU beds, experienced nursing support, and robust coordination for international families. The institute is well-equipped for bone marrow and stem cell transplantation, with seamless integration of supportive care, infectious disease expertise, and nutritional rehabilitation. For international patients and their families, Dr. Rela Institute offers dedicated patient liaison services, English-speaking staff, and accommodation support, making Chennai an accessible destination for paediatric hemato-oncology care.

Dr. Sujith Kumar Mullapally is a Consultant in Medical Oncology at Apollo Proton Cancer Centre in Chennai, bringing over 9 years of dedicated clinical experience in comprehensive cancer care. He holds strong academic credentials including an MBBS, MD in Radiotherapy from All India Institute of Medical Sciences (AIIMS) New Delhi, and a DM in Medical Oncology from Tata Memorial Hospital under the Homi Bhabha National Institute in Mumbai. His training at these premier institutions has positioned him as a well-rounded physician with deep expertise in systemic oncology. Dr. Mullapally specializes in a broad range of modern cancer therapies, including chemotherapy for solid tumors, immunotherapy with immune checkpoint inhibitors, molecular targeted therapy, and biomarker-based personalized treatment approaches. He is skilled in administering adjuvant and neoadjuvant chemotherapy protocols, hormone therapy for breast and prostate cancers, and low-dose metronomic chemotherapy regimens. His clinical depth is reflected in his commitment to evidence-based medicine and adoption of the latest research findings in his practice. He has earned recognition for his clinical contributions, including the M. Jagadeesan Award for Young Radiation Oncology, which underscores his standing as a rising leader in oncology. Prior to his current role, Dr. Mullapally served as Head of the Oncology Department at Aster MIMS in Kannur, Kerala, and as a Specialist Registrar at Tata Memorial Centre in Mumbai—one of Asia's most respected comprehensive cancer centers. He welcomes international patients from the Gulf, South Asia, and Africa, and brings a patient-centered approach to complex oncology cases. Apollo Proton Cancer Centre is equipped with advanced radiation and systemic therapy facilities, making it an ideal destination for comprehensive cancer treatment. The centre combines cutting-edge technology with experienced multidisciplinary teams, offering seamless care coordination for both local and international patients. International patients choosing treatment at Apollo benefit from streamlined admissions, translator support, and dedicated patient care coordinators. Dr. Mullapally's fluency in English, Hindi, and Tamil ensures clear communication and personalized care planning for patients from diverse backgrounds.